Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Carney

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Virology|July 18, 2018
Monoclonal antibody against N2 neuraminidase of cold adapted A/Leningrad/134/17/57 (H2N2) enables efficient generation of live attenuated influenza vaccinesSvetlana Shcherbik, Paul Carney, Nicholas Pearce, et al.
Cureus|June 10, 2024
Importance of Genetic Testing in Children With Generalized EpilepsyMadison Heebner, Gayatra Mainali, Sharon Wei, et al.
Mbio|February 3, 2021
Antibody Landscape Analysis following Influenza Vaccination and Natural Infection in Humans with a High-Throughput Multiplex Influenza Antibody Detection AssayZhu-Nan Li, Feng Liu, F Liaini Gross, et al.
Vaccine: X|August 7, 2019
Evaluation of A(H1N1)pdm09 LAIV vaccine candidates stability and replication efficiency in primary human nasal epithelial cellsSvetlana Shcherbik, Nicholas Pearce, Paul Carney, et al.
Antiviral Research|November 8, 2016
An influenza A virus (H7N9) anti-neuraminidase monoclonal antibody with prophylactic and therapeutic activity in vivoJason R Wilson, Zhu Guo, Adrian Reber, et al.
Influenza and Other Respiratory Viruses|November 9, 2019
Identification of novel influenza A virus exposures by an improved high-throughput multiplex MAGPIX platform and serum adsorptionZhu-Nan Li, Emily Cheng, Eugenie Poirot, et al.
Plos One|June 28, 2018
Development of a high-throughput assay to detect antibody inhibition of low pH induced conformational changes of influenza virus hemagglutininJessica F Trost, Elizabeth H LeMasters, Feng Liu, et al.
EC Psychology and Psychiatry|February 1, 2024
Evidence Based Clinical Analytics Supporting the Genetic Addiction Risk Severity (GARS) Assessment to Early Identify Probands in PreaddictionKenneth Blum, Abdalla Bowirrat, Panayotis K Thanos, et al.
Virology|September 10, 2017
An influenza A virus (H7N9) anti-neuraminidase monoclonal antibody protects mice from morbidity without interfering with the development of protective immunity to subsequent homologous challengeJason R Wilson, Jessica A Belser, Juliana DaSilva, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 10, 2022
Multiplex Detection of Antibody Landscapes to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/Influenza/Common Human Coronaviruses Following Vaccination or Infection With SARS-CoV-2 and InfluenzaZhu Nan Li, Feng Liu, Stacie Jefferson, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Virology|July 18, 2018
Monoclonal antibody against N2 neuraminidase of cold adapted A/Leningrad/134/17/57 (H2N2) enables efficient generation of live attenuated influenza vaccinesSvetlana Shcherbik, Paul Carney, Nicholas Pearce, et al.
Cureus|June 10, 2024
Importance of Genetic Testing in Children With Generalized EpilepsyMadison Heebner, Gayatra Mainali, Sharon Wei, et al.
Mbio|February 3, 2021
Antibody Landscape Analysis following Influenza Vaccination and Natural Infection in Humans with a High-Throughput Multiplex Influenza Antibody Detection AssayZhu-Nan Li, Feng Liu, F Liaini Gross, et al.
Vaccine: X|August 7, 2019
Evaluation of A(H1N1)pdm09 LAIV vaccine candidates stability and replication efficiency in primary human nasal epithelial cellsSvetlana Shcherbik, Nicholas Pearce, Paul Carney, et al.
Antiviral Research|November 8, 2016
An influenza A virus (H7N9) anti-neuraminidase monoclonal antibody with prophylactic and therapeutic activity in vivoJason R Wilson, Zhu Guo, Adrian Reber, et al.
Influenza and Other Respiratory Viruses|November 9, 2019
Identification of novel influenza A virus exposures by an improved high-throughput multiplex MAGPIX platform and serum adsorptionZhu-Nan Li, Emily Cheng, Eugenie Poirot, et al.
Plos One|June 28, 2018
Development of a high-throughput assay to detect antibody inhibition of low pH induced conformational changes of influenza virus hemagglutininJessica F Trost, Elizabeth H LeMasters, Feng Liu, et al.
EC Psychology and Psychiatry|February 1, 2024
Evidence Based Clinical Analytics Supporting the Genetic Addiction Risk Severity (GARS) Assessment to Early Identify Probands in PreaddictionKenneth Blum, Abdalla Bowirrat, Panayotis K Thanos, et al.
Virology|September 10, 2017
An influenza A virus (H7N9) anti-neuraminidase monoclonal antibody protects mice from morbidity without interfering with the development of protective immunity to subsequent homologous challengeJason R Wilson, Jessica A Belser, Juliana DaSilva, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 10, 2022
Multiplex Detection of Antibody Landscapes to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/Influenza/Common Human Coronaviruses Following Vaccination or Infection With SARS-CoV-2 and InfluenzaZhu Nan Li, Feng Liu, Stacie Jefferson, et al.
Pageof 4